Title: 131st Annual Meeting of the American Public Health Association-Program Highlights
Author:
Section/SPIG: HIV/AIDS
Issue Date:
There are many exciting general sessions at this year’s Annual Meeting, but we would like to call your attention to the following three:
· President’s Session (3256.1) Monday, Nov. 17, 2:30 P.M.-4:00 P.M.
· Critical Issues in Public Health (4088.1) Tuesday, Nov. 18, 10:30 A.M.-12:00 P.M.
· APHA Closing Session (5190.0) Wednesday, Nov. 19, 4:30 P.M.-6:00 P.M.
Each session will include presentations on issues of great importance to the fulfillment of the public health mission in the 21st century by panels of outstanding experts. The panels are designed to provoke participants to view the future of their profession and to develop strategies for assuring public health effectiveness in the future.
Brief descriptions of these Sessions are provided below. For further information on the Sessions, go to <www.apha.org/meetings/sessions.htm>.
President’s Session
This session will focus on the challenges and opportunities facing public health in the 21st century. Topics to be discussed are: the Institute of Medicine’s recommendations on the future of public health practice and education; strategies to eliminate health disparities; mobilizing public support for universal health care; and a summary of the present state of public health as a “starting point” for the future.
Critical Issues in Public Health
This Session will further amplify the discussion of issues of central concern in the 21st century. The topics to be covered in this session are: new strategies to reduce the prevalence of substance abuse; approaches towards controlling the epidemic of obesity; strategies to reduce the high incidence of traffic accidents; and dealing with the threat of emerging zoonotic infections.
Closing General Session
For the first time, the Closing General Session will feature a panel discussion. Three areas of central concern to public health in the 21st century will be discussed. The topics to be covered are: the impact of the rapidly advancing science of genomics on public health; the threat of new and emerging infectious diseases; and the promise of technology in helping disabled people to overcome their physical limitations.